Status:

COMPLETED

Lung Ultrasound for COVID-19 Initial Triage and Monitoring

Lead Sponsor:

University Hospital, Toulouse

Conditions:

COVID-19

Acute Respiratory Failure

Eligibility:

All Genders

17+ years

Brief Summary

The QUICK study main aim is to assess the predictive value at Day 1, of a model built on lung ultrasound (LUS) and clinical data, both recorded at hospital admission of COVID-19 patients.

Detailed Description

Initial triage assessment is the cornerstone of first-line medical management for COVID-19 patients. Only an accurate and fast evaluation of COVID-19 patients respiratory system integrity, can allow o...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Adult (\> 18 years).
  • Proven COVID-19 (specific PCR from respiratory track sample)
  • CT scan prescribed by physician in charge, independently of research.
  • Patients consent (or surrogate decision maker's consent in case of need).
  • Exclusion criteria:
  • Reduction or cessation of active treatment.
  • Patient under guardianship, tutelage measure or judicial protection
  • Patient deprived of liberty by judicial order
  • No French health insurance.
  • Pregnancy or nursing woman.
  • Enrolled in another trial evaluating thoracic imaging.

Exclusion

    Key Trial Info

    Start Date :

    May 27 2020

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    March 7 2021

    Estimated Enrollment :

    25 Patients enrolled

    Trial Details

    Trial ID

    NCT04474236

    Start Date

    May 27 2020

    End Date

    March 7 2021

    Last Update

    June 1 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University Hospital Toulouse

    Toulouse, France

    Lung Ultrasound for COVID-19 Initial Triage and Monitoring | DecenTrialz